Phase I study of FR901228 [romidepsin] in patients with advanced malignant solid tumors or lymphomas and varying levels of liver dysfunction
Phase of Trial: Phase I
Latest Information Update: 22 Dec 2005
At a glance
- Drugs Romidepsin (Primary)
- Indications Lymphoma; Solid tumours
- Focus Adverse reactions
- 22 Dec 2005 New trial record.